Announcements

Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA

MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.

The following MDPI journals will be represented:

• JCM;
• Medicina;
• Clinics and Practice;
• JPM;
• Cancers;
• Medicines;
• Healthcare;
• Metabolites;
• Children;
• Brain Sciences.

If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.

Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark

MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.

The following MDPI journals will be represented:

• Children;
• Behavioral Sciences;
• JCM;
• JPM;
• Medicina;
• Adolescents;
• Disabilities.

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.

We are pleased to announce that the EURLYAID International Early Childhood Intervention Conference has set up a free media partnership with Children (ISSN: 2227-9067).

Conference: EURLYAID International Early Childhood Intervention Conference
Date: 15–16 May 2023
Place: Prague, Czech Republic

The aim of the conference, titled "Building bridges together in early childhood intervention", is to connect specialized fields and create multidisciplinary teams and comprehensive support for families caring for children with special needs. We include parents in the role of experts, as they know their children's needs best and are therefore equal partners with early childhood intervention (ECI) consultants and other specialists.

Top experts on ECI from all over the world, and other leading professionals from the Czech Republic and abroad will participate in the conference. Contributions will be made by speakers from the field of ECI as well as many other collaborating professions.

Visit the conference website for more information at www.eciprague.com. Registration is open until 26 April 2023.

Children Editorial Office

Pharmacotherapy is a very powerful intervention to improve outcome, and this is also true in neonates. The prescription of a given drug should result in a safe and effective intervention to treat or prevent a specific disease or risk in an individual patient or population while avoiding disproportional side effects. Clinical pharmacology supports these aims in predicting drug-related (side) effects driven by pharmacokinetics (PK) and pharmacodynamics (PD). The dynamic changes related to maturation and growth in newborns result in a unique setting with extensive variability. Non-maturational changes (such as disease characteristics, drug–drug interactions, pharmacogenetics, and lactation-related exposure) further add to this variability.

This is a growing and active field of clinical research, with several reports on PK, PD, pharmacovigilance and -safety, and pharmaco-epidemiology having been published. This clinical field is further supported by novelties in the methods that are currently available (low-volume sample analysis, population PK analysis, physiology-based PK).

Date: 5 May 2023, at 11:00 a.m. CEST | 5:00 a.m. EST | 5:00 p.m. CST Asia
ID: 880 0570 9862

Chair and Speakers

Program:

Relevant SI

Neonatal Clinical Pharmacology
Guest Editor: Prof. Dr. Karel Allegaert, Dr. Nadir Yalcin, Dr. Robert B. Flint and Dr. Sinno H.P. Simons
Deadline for manuscript submissions: 25 August 2023

This is a free webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized. Certificates of attendance will be delivered to those who attend the live webinar.

Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.

On 7 April 2023—World Health Day, the World Health Organization (WHO) will observe its 75th anniversary. In 1948, countries of the world came together and founded the WHO to promote health, keep the world safe, and serve the vulnerable, so that everyone, everywhere, can attain the highest level of health and well-being. The WHO’s 75th anniversary is an opportunity to look back at public health successes that have improved quality of life over the last seven decades. It is also an opportunity to motivate action to tackle the health challenges of today and tomorrow. In order to encourage everyone to understand health and pay attention to health, we have also curated a list of publications on topics related to universal health coverage, healthy diet, and mental health. We also want to remind everyone that all research published in MDPI journals is available in an open access format, allowing practitioners, policy makers, and people around the world to access the latest scientific knowledge to build upon and share. Although we still have a long way to go to achieve universal health, this day also provides an opportunity to celebrate the progress made and inspire further action toward a more just and equitable world. Join us on a journey at MDPI to achieve Health for All.

• The Antioxidant Potential of the Mediterranean Diet as a Predictor of Weight Loss after a Very Low-Calorie Ketogenic Diet (VLCKD) in Women with Overweight and Obesity

  Antioxidants 2023, 12(1), 18; https://doi.org/10.3390/antiox12010018

• Effectiveness of Non-Contact Dietary Coaching in Adults with Diabetes or Prediabetes Using a Continuous Glucose Monitoring Device: A Randomized Controlled Trial

  Healthcare 2023, 11(2), 252; https://doi.org/10.3390/healthcare11020252

• The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data

  Nutrients 2023, 15(6), 1501; https://doi.org/10.3390/nu15061501

• Physical Exercise and Diet: Regulation of Gut Microbiota to Prevent and Treat Metabolic Disorders to Maintain Health

  Nutrients 2023, 15(6), 1539; https://doi.org/10.3390/nu15061539

• Modelling and Prediction of the Spread of COVID-19 in Cameroon and Assessing the Governmental Measures (March–September 2020)

  COVID 2021, 1(3), 622-644; https://doi.org/10.3390/covid1030052

• SARS-CoV-2 Infection in Health Care Workers of Trieste (North-Eastern Italy), 1 October 2020–7 February 2022: Occupational Risk and the Impact of the Omicron Variant

  Viruses 2022, 14(8), 1663; https://doi.org/10.3390/v14081663

• Vaccination Coverage during Childhood and Adolescence among Undergraduate Health Science Students in Greece

  Children 2022, 9(10), 1553; https://doi.org/10.3390/children9101553

• Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era

  Vaccines 2023, 11(3), 680; https://doi.org/10.3390/vaccines11030680

• Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)

  Brain Sci. 2022, 12(5), 590; https://doi.org/10.3390/brainsci12050590

• Impact on Students of the Act–Belong–Commit Mentally Healthy Schools Framework

  Children 2023, 10(3), 548; https://doi.org/10.3390/children10030548

• Psychological Health and Drugs: Data-Driven Discovery of Causes, Treatments, Effects, and Abuses

  Toxics 2023, 11(3), 287; https://doi.org/10.3390/toxics11030287

• Characterizing Touch Discrimination Impairment from Pooled Stroke Samples Using the Tactile Discrimination Test: Updated Criteria for Interpretation and Brief Test Version for Use in Clinical Practice Settings

  Brain Sci. 2023, 13(4), 533; https://doi.org/10.3390/brainsci13040533

Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy

MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.

The following MDPI journals will be represented:

• Cells;
• Cancers;
• Children;
• CIMB;
• Current Oncology;
• Diagnostics;
• Geriatrics;
• Healthcare;
• JCM;
• Medical Sciences.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.

Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.

The following MDPI journals will be represented:

• Pharmaceuticals (leading journal);
• Biomedicines;
• JPM;
• JCM;
• Marine Drugs;
• Children;
• Current Oncology;
• BioMedInformatics;
• JoX;
• Rheumato.

If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at pharmaceuticals@mdpi.com.

Children (ISSN 2227-9067) has launched the Section “Child Neurology”, which is dedicated to publishing papers on the diagnosis and treatment of child and adolescent neurological disorders. These include diagnosis, therapy, supportive care, long-term outcomes, epidemiology and disease prevention, and the economic impact of pediatric neurological disorders (both on the patient and the healthcare system).

We welcome you to read the highly cited and highly accessed Special Issues. As Children is an Open Access publication, you have free and unlimited access to the full text of all the articles published in our journal.

1. “Cognitive Neuroscience and Neuropsychiatry in Infancy and Early Childhood Development”
Edited by Michelle de Haan
Webpage: https://www.mdpi.com/journal/children/special_issues/Neuroscience_Neuropsychiatry_Infancy_Childhood
Viewed by 6,714 | Cited by 3

2. “Cognitive and Linguistic Development in Children and Adolescents”
Edited by Irene Cadime, Iolanda Ribeiro and Maria Luisa Lorusso
Webpage: https://www.mdpi.com/journal/children/special_issues/U4024A0PGF
Viewed by 6,437 | Cited by 1

3. “Advances in Autism Research: Diagnosis, Treatment and Best Practices”
Edited by Raffaella Devescovi and Antonio Narzisi
Webpage: https://www.mdpi.com/journal/children/special_issues/Autism_Diagnosis_Treatment_Practices
Viewed by 4,852 | Cited by 4

4. “Advances in Pediatric Neuromuscular Disorders”
Edited by Rohan Sharma and Aravindhan Veerapandiyan
Webpage: https://www.mdpi.com/journal/children/special_issues/Advances_Pediatric_Neuromuscular_disorders
Viewed by 2,614 | Cited by 0

5. “Diagnosis and Treatment in Childhood Epilepsy”
Edited by Debopam Samanta
Webpage: https://www.mdpi.com/journal/children/special_issues/Diagnosis_Childhood_Epilepsy
Viewed by 2,347 | Cited by 1

As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.

In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.

If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to newjournal-committee@mdpi.com.

MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page. 

We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.